The 3rd international conference on Influenza Vaccines for the World (IVW 2009).
Yedidia
Tamar Ben
TB
BiondVax Pharmaceuticals Ltd, Ness Ziona, Israel. benyedidia@biondvax.com
D000818:Animals; D002986:Clinical Trials as Topic; D014943:Global Health; D006801:Humans; D007218:Industrial Microbiology / Q000379:methods; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000276:immunology* / Q000592:standards* / Q000627:therapeutic use; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000276:immunology / Q000821:virology; D022223:Vaccines, Subunit / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology / Q000592:standards / Q000627:therapeutic use
D007252:Influenza Vaccines; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic